Aspire Food Group

its London, Ontario cricket-protein plant — billed as the world's largest cricket farm and backed by tens of millions of dollars in Canadian federal funding — was placed into receivership reportedly owing C$41.5 million.

Country
United States
Coverage
EUINUS
food-alt-protein
Regulatorsefsafda

Verifiable facts

FactValueSource
Fundingtens of millions of dollars in federal grants and loans, including $8.5 million from Agriculture and Agri-Food Canada (AAFC) and approximately $41.5 million in debt owed to Farm Credit Canada (FCC) at the time of receivership.agfundernews.com · search.open.canada.ca · canada.ca · cbc.ca
CapacityDesigned for up to 13 million kilograms (12,000 metric tons) of cricket production annually, but operated at significantly less than full capacity (half capacity or below) before receivership.agfundernews.com · lfpress.com · cbc.ca
Production site2450 Innovation Drive, London, Ontario; also maintained a research and development facility in Austin, Texas.cfcanada.fticonsulting.com · lfpress.com · cbc.ca
HeadcountHad approximately 150 employees before laying off over 100 workers; reported to employ about 50 workers while in receivership.cfcanada.fticonsulting.com · lfpress.com · cbc.ca
CertificationNo specific certifications for the London, Ontario plant were explicitly listed in the provided documents. medium confidencecbc.ca · marketresearchfuture.com · verifiedmarketreports.com
Regulatory approvalNo specific regulatory approvals for the London, Ontario plant were explicitly listed in the provided documents. medium confidencemarketresearchfuture.com · verifiedmarketreports.com

Independent sources: agfundernews.com · canada.ca · cbc.ca · cfcanada.fticonsulting.com · lfpress.com · marketresearchfuture.com · search.open.canada.ca · verifiedmarketreports.com

Technologies
NameClusterRisk
Industrial insect farmingfood-alt-proteinHigh

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.